Growth factors in the treatment of acute lymphoblastic leukemia

Leukemia Research

Volumn 22, Issue 12, 1998, Pages 1171-1178

  Ottmann, Oliver G ^a   Hoelzer, Dieter ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE DERIVATIVE; CYTARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH FACTOR; MITOXANTRONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANTIBIOTIC THERAPY; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DRUG EFFECT; DRUG EFFICACY; HOSPITALIZATION; HUMAN; INFECTION; INTRAVENOUS DRUG ADMINISTRATION; METHODOLOGY; NEUTROPENIA; PRIORITY JOURNAL; REVIEW; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0032438289     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(98)00116-7     Document Type: Article

References (30)

1. Hoelzer D. Treatment of acute lymphoblastic leukemia. Semin Hematol. 31:1994;1.
2. Weiss M., Telford M.W., Kempin S., Kritz A., Sogoloff H., Gee T., Berman E., Scheinberg D., Little C., Gaynor J., Belanger C., Bertino J., Andreef M., McKenzie S., Clarkson B. Severe toxicity limits intensification of induction therapy for acute lymphoblastic leukemia [abstract]. Leukemia. 7:1993;832.
3. Copelan E.A., McGuire E.A. The biology and treatment of acute lymphoblastic leukemia in adults. Blood. 85:1995;1151.
4. Ad hoc Colony-Stimulating Factor Guidelines Expert Panel American Society of Clinical Oncology recommendations for the use of hematopoietic colony-stimulating factors: Evidence based, clinical practice guidelines. J Clin Oncol. 12:1994;2471.
5. Ad hoc Colony-Stimulating Factor Guidelines Expert Panel Update of recommendations for the use of hematopoietic colony-stimulating factors: Evidence based, clinical practice guidelines. J Clin Oncol. 14:1996;1957.
6. Ottmann O.G., Hoelzer D. Do G-CSF and GM-CSF contribute to the management of acute lymphoblastic leukemia? Leukemia. 10(Suppl 2):1996;52.
7. Ohno R., Tomonaga M., Kobayashi T., Kanamaru A., Shirakawa S., Masaoka T., Omine M., Oh H., Nomura T., Sakai Y., Hirano M., Yokomaku S., Nakayama S., Yoshida Y., Miura A.B., Morishima Y., Dohy H., Niho Y., Hamajima N., Takaku F. Effect of granulocyte colony-stimulating factor after intensive induction therapy in relapsed or refractory acute leukemia. New Engl J Med. 323:1990;871.
8. Ohno R., Tomonaga M., Ohshima T., Masaoka T., Asou N., Oh H., Nishikawa K., Kanamaru A., Murakami H., Furusawa S.et al. A randomized controlled study of granulocyte colony stimulating factor after intensive induction and consolidation therapy in patients with acute lymphoblastic leukemia. Int J Hematol. 58:1993;73.
9. Kantarjian H.M., Estey E., O'Brien S., Anaissie E., Beran M., Pierce S., Robertson L., Keating M.J. Granulocyte colony-stimulating supportive treatment following intensive chemotherapy in acute lymphocytic leukemia in first remission. Cancer. 72:1993;2950.
10. Kantarjian H.M., Estey E.H., O'Brien S., Anaissie E., Beran M., Rios M.B., Keating M.J., Gutterman J. Intensive chemotherapy with mitoxantrone and high-dose cytosine arabinoside followed by granulocyte macrophage colony-stimulating factor in the treatment of patients with acute lymphocytic leukemia. Blood. 79:1992;876.
11. Welte K., Mempel K., Reiter A.et al. A randomised phase III study of the efficacy of granulocyte-colony stimulating factor in children with high risk acute lymphoblastic leukemia. Blood. 87:1996;3143.
12. Pui C.-H., Boyett J.M., Hughes W.T., Rivera G.K., Hancock M.L., Sandlund J.T., Synold T., Relling M.V., Ribeiro R.C., Crist W.M., Evans W.E. Human granulocyte colony-stimulating factor after induction chemotherapy in children with acute lymphoblastic leukemia. New Engl J Med. 336:1997;1781.
13. Papamichael D., Andrews T., Owen D., Carter M., Amess J., Lister T.A., Rohatiner A. Intensive chemotherapy for adult acute lymphoblastic leukaemia given with or without granulocyte-macrophage colony-stimulating factor. Ann Hematol. 73:1996;259.
14. Mortillo M., Tedeschi A., Centurioni R., Leoni P. Treatment of relapsed adult acute lymphoblastic leukemia with fludarabine and cytosine arabinoside followed by granulocyte colony-stimulating factor (FLAG-GCSF). Leuk Lymphoma. 25:1997;579.
15. Scherrer R., Geissler K., Kyrle P.A., Gisslinger H., Jager U., Bettelheim P., Laczika K., Locker G., Scholten C., Sillaber C., Lechner K. Granulocyte colony-stimulating factor (G-CSF) as an adjunct to induction chemotherapy of adult acute lymphoblastic leukemia (ALL). Ann Hematol. 66:1993;283.
16. Ottmann O.G., Ganser A., Freund M., Heil G., Hiddemann W., Heit W., Gracien E., Hoelzer D. Simultaneous administration of granulocyte colony-stimulating factor (Filgrastim) and induction chemotherapy in acute lymphoblastic leukemia - A pilot study. Ann Hematol. 67:1993;161.
17. Ottmann O.G., Hoelzer D., Gracien E., Ganser A., Kelly K., Reutzel R., Lipp T., Busch F.W., Schwonzen M., Heil G., Wandt H., Koch P., Kolbe K., Heyll A., Bentz M., Peters S., Diedrich H., Dethling J., Meyer P., Nowrousian M.R., Löffler B., Weiss A., Kneba M., Hartmann W., Graf M., Hecht T. Concomitant granulocyte colony-stimulating factor and induction chemoradiotherapy in adult acute lymphoblastic leukemia: a randomized phase III trial. Blood. 86:1995;444.
18. Geissler K., Koller E., Hubmann E., Niederwieser D., Hinterberger W., Geissler D., Kyrle P., Knöbl P., Pabinger I., Thalhammer R., Schwarzinger I., Mannhalter C., Jaeger U., Heinz R., Linkesch W., Lechner K. Granulocyte colony-stimulating factor as an adjunct to induction chemotherapy for adult acute lymphoblastic leukemia - A randomized phase III study. Blood. 90:1997;590.
19. Dibenedetto S.P., Ragusa R., Ippolito A.M., Lo-Nigro L., Di-Cataldo A., D'Amico S., Miraglia V. Assessment of the value of treatment with granulocyte colony-stimulating factor in children with acute lymphoblastic leukemia: a randomized clinical trial. Eur J Haematol. 55:1995;93.
20. Calderwood S., Romeyer F., Blanchette V., Chan H., Doyle J., Greenberg M., Lorenzana A., Malkin D., Saunders F., Weitzman S., Zipursky A., Freedman M.H. Concurrent RhGM-CSF does not offset myelosuppression from intensive chemotherapy: randomized placebo-controlled study in childhood acute lymphoblastic leukemia. Am J Hematol. 47:1994;27.
21. Mitchell P.L.R., Morland B., Stevens M.C.G.et al. Granulocyte colony-stimulating factor in established febrile neutropenia: a randomized study of pediatric patients. J Clin Oncol. 15:1997;1163.
22. Elonen E., Jantunen E., Koistinen P., Koivunen E., Lehtinen M., Nousiainen T., Pelliniemi T.-T., Remes K., Sinisalo M., Timonen T., Volin L., Ruutu T. G-CSF (lenograstim) following chemotherapy in the induction treatment of acute lymphoblastic leukemia (ALL) in adults. A randomized study between early and delayed start [abstract]. Blood. 88(Suppl 1):1996;842.
23. Bassan R., Lerede T., Di Bona E., Rossi G., Pogliani E., Rambaldi A., Buelli M., Viero P., Rodeghiero F., Izzi T., Corneo G., Barbui T. Granulocyte colony-stimulating factor (G-CSF, filgrastim) after or during an intensive remission induction therapy for adult acute lymphoblastic leukaemia: effects, role of patient pretreatment characteristics, and costs. Leuk Lymphoma. 26:1997;153.
24. Visani G., Tosi P., Zinzani P.L., Manfroi S., Ottaviani E., Cenacchi A., Carrara P., Clavio M., Gobbi M., Tura S. FLAG (fludarabine, cytarabine, G-CSF) as a second line therapy for acute lymphoblastic leukemia with myeloid antigen expression: in vitro and in vivo effects. Eur J Haematol. 56:1996;308.
25. Suki S., Kantarjian H., Gandhi V., Estey E., O'Brian S., Bera M., Rios M.B., Plunkett W., Keating M. Fludarabine and cytosine arabinoside in the treatment of refractory or relapsed acute lymphocytic leukemia. Cancer. 72:1994;2155.
26. Drexler H.G., Thiel E., Ludwig W.D.et al. Review of incidence and clinical relevance of myeloid antigen-positive acute lymphoblastic leukemia. Leukemia. 5:1991;637.
27. Komada Y., Zhou Y.W., Zhang S.L.et al. Role in growth regulation of cytokines and cytokine receptors in acute lymphoblastic leukemia expressing myeloid markers. Br J Haematol. 84:1993;408.
28. Tsuchiya H., Asou N., Watanabe M.et al. Myeloid antigen expression in childhood acute lymphoblastic leukemia. New Engl J Med. 325:1991;1380.
29. Meropol N.J., Miller L.L., Korn E.L., Braitman L.E., MacDermott M.L., Schuchter L.M. Severe myelosuppression resulting from concurrent administration of granulocyte colony-stimulating factor and cytotoxic chemotherapy. J Natl Cancer Inst. 84:1992;1201.
30. Hoelzer D. Hemopoietic growth factors - not whether, but when and where. New Engl J Med. 336:1997;1822-1824.